Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $415.32 | 33 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $68.80 | 4 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $61.70 | 4 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $45.25 | 9 | $0 (2018) |
| Allergan Inc. | $43.75 | 2 | $0 (2018) |
| PFIZER INC. | $38.26 | 3 | $0 (2018) |
| GlaxoSmithKline, LLC. | $25.24 | 2 | $0 (2018) |
| Daiichi Sankyo Inc. | $21.16 | 1 | $0 (2018) |
| Ironwood Pharmaceuticals, Inc | $18.66 | 1 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $16.48 | 1 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.24 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $258.66 | 23 | Takeda Pharmaceuticals U.S.A., Inc. ($45.25) |
| 2017 | $156.66 | 10 | SANOFI-AVENTIS U.S. LLC ($55.23) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/16/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/13/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, GLYXAMBI | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: DIABETES | ||||||
| 10/30/2018 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/16/2018 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: Central Nervous System | ||||||
| 10/09/2018 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $10.49 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2018 | PFIZER INC. | LYRICA (Drug), XTANDI | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 08/28/2018 | Allergan Inc. | BYSTOLIC (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/07/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/31/2018 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: DIABETES | ||||||
| 07/17/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: RESPIRATORY | ||||||
| 07/11/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $8.60 | General |
| Category: Central Nervous System (CNS) | ||||||
| 07/11/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $0.55 | General |
| Category: Central Nervous System (CNS) | ||||||
| 06/20/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $8.61 | General |
| Category: Central Nervous System (CNS) | ||||||
| 06/20/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $2.75 | General |
| Category: Central Nervous System (CNS) | ||||||
| 06/20/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $0.78 | General |
| Category: Central Nervous System (CNS) | ||||||
| 06/06/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $8.25 | General |
| Category: Central Nervous System (CNS) | ||||||
| 06/06/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Dexilant (Drug) | Food and Beverage | In-kind items and services | $0.20 | General |
| Category: Upper GI | ||||||
| 06/05/2018 | Lilly USA, LLC | FORTEO (Drug) | Food and Beverage | In-kind items and services | $10.53 | General |
| Category: Bone Muscle Joint | ||||||
| 05/11/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Central Nervous System (CNS) | ||||||
| 05/11/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $2.50 | General |
| Category: Central Nervous System (CNS) | ||||||
| 01/23/2018 | Daiichi Sankyo Inc. | Morphabond ER (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Pain Management | ||||||
| 12/05/2017 | PFIZER INC. | VIAGRA (Drug), LYRICA, EUCRISA | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);CARDIOVASCULAR;RESPIRATORY | ||||||
| 12/01/2017 | GlaxoSmithKline, LLC. | BOOSTRIX (Biological), FLUARIX, SHINGRIX | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 300 | 586 | $205,461 | $42,426 |
| 2022 | 7 | 304 | 613 | $209,307 | $43,053 |
| 2021 | 9 | 388 | 722 | $217,936 | $51,639 |
| 2020 | 5 | 225 | 366 | $95,919 | $18,815 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 227 | 467 | $183,245 | $37,044 | 20.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 36 | 36 | $14,175 | $4,323 | 30.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 12 | $3,120 | $603.80 | 19.4% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 15 | 15 | $4,110 | $408.94 | 9.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 11 | 56 | $811.00 | $46.67 | 5.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 205 | 450 | $170,808 | $35,602 | 20.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 27 | 27 | $10,252 | $3,394 | 33.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 12 | 12 | $7,012 | $1,924 | 27.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 12 | 22 | $12,089 | $933.43 | 7.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 15 | $3,868 | $745.41 | 19.3% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 16 | 16 | $4,284 | $392.52 | 9.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 17 | 71 | $994.00 | $62.93 | 6.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 262 | 536 | $197,769 | $45,616 | 23.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 17 | 17 | $6,292 | $2,054 | 32.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 16 | 27 | $6,713 | $1,145 | 17.1% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 19 | 19 | $1,102 | $1,044 | 94.7% |
| 0003A | Fee covid-19 vac 1 booster | Office | 2021 | 16 | 16 | $960.00 | $610.56 | 63.6% |
| 0013A | Fee covid-19 vac 2 booster | Office | 2021 | 13 | 13 | $780.00 | $496.08 | 63.6% |
| 69210 | Removal of impact ear wax, one ear | Office | 2021 | 12 | 12 | $3,172 | $308.98 | 9.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 22 | 22 | $308.00 | $308.00 | 100.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 11 | 60 | $840.00 | $55.39 | 6.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 164 | 259 | $93,324 | $17,216 | 18.4% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 16 | 16 | $922.00 | $864.00 | 93.7% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 11 | 12 | $567.00 | $351.05 | 61.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 23 | 23 | $322.00 | $322.00 | 100.0% |
About Dr. Carter Aune, M.D
Dr. Carter Aune, M.D is a Family Medicine healthcare provider based in Hartford, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174580724.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carter Aune, M.D has received a total of $415.32 in payments from pharmaceutical and medical device companies, with $258.66 received in 2018. These payments were reported across 33 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($415.32).
As a Medicare-enrolled provider, Aune has provided services to 1,217 Medicare beneficiaries, totaling 2,287 services with total Medicare billing of $155,933. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Hartford, WI
- Active Since 04/27/2006
- Last Updated 12/18/2018
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1174580724
Products in Payments
- FARXIGA (Drug) $61.70
- Trintellix (Drug) $45.05
- PRALUENT (Drug) $37.98
- SOLIQUA (Drug) $30.82
- BYSTOLIC (Drug) $23.84
- Morphabond ER (Drug) $21.16
- LINZESS (Drug) $19.91
- DUZALLO (Drug) $18.66
- ENTRESTO (Drug) $16.48
- TRADJENTA (Drug) $15.24
- XIFAXAN (Drug) $14.32
- Nucynta (Drug) $13.58
- VIAGRA (Drug) $13.54
- EMBEDA (Drug) $13.05
- BOOSTRIX (Biological) $12.96
- BREO (Drug) $12.28
- AJOVY (Drug) $11.86
- LYRICA (Drug) $11.67
- FORTEO (Drug) $10.53
- VYVANSE (Drug) $10.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Hartford
Mohammad Samer Younes, M.d, M.D
Family Medicine — Payments: $16,845
Mark Belsky, Md, MD
Family Medicine — Payments: $7,778
Dr. Nieves Hornbeck, M.d, M.D
Family Medicine — Payments: $7,619
Charlecinth Roberts, Md, MD
Family Medicine — Payments: $7,389
Susan Wiskowski, Md, MD
Family Medicine — Payments: $4,449
Sama Alvi, M.d, M.D
Family Medicine — Payments: $4,362